Expandable bone and tissue regeneration system, and applications of same
The disclosure relates to an expandable scaffold and a method for fabricating the scaffold. The expandable scaffold includes a three-dimensional porous structure comprising a composite material composed by a first material and a second material. The 3D porous structure has a tunable expansion capacity. When applied in a liquid, the 3D porous structure may uptake the liquid and expand from an original volume to an expansion volume up to 1000 times of the original volume. The 3D porous structure may be formed by a plurality of layers of the composite material, and architecture and shape of the layers of the composite material are arranged in accordance with a shape and a size of the expansion volume. Applications of the scaffold may include a bone or soft tissue regeneration system or a bleed stopping device.
1. An expandable scaffold, comprising:
a three-dimensional (3D) porous structure comprising a composite material composed by a first material and a second material,
wherein the first material comprises a mixture of a first biocompatible and biodegradable polyurethane polymer having a linear expansion of 100.44%, and a second biocompatible and biodegradable polyurethane polymer having a linear expansion of 42.11%, wherein a mass ratio of the first biocompatible and biodegradable polyurethane polymer to the second biocompatible and biodegradable polyurethane polymer is in a range from 1/1 to 9/1;
wherein the 3D porous structure has a tunable expansion capacity, and when applied in a liquid, is configured to uptake the liquid and expand from an original volume to an expansion volume up to 10000 times of the original volume; and
wherein a mass ratio of the second material to the expandable scaffold is equal to or greater than 60%.
2. The expandable scaffold of claim 1 , wherein the 3D porous structure is formed by a plurality of layers of the composite material, and the layers of the composite material are arranged in accordance with a shape and a size of the expansion volume.
3. The expandable scaffold of claim 1 , wherein the liquid is water or bodily fluid of a living subject.
4. The expandable scaffold of claim 3 , wherein the 3D porous structure, when disposed in a bone defect or a tissue defect of the living subject, uptakes bodily fluid of the living subject and expands to self-fit in the bone defect or the tissue defect.
5. The expandable scaffold of claim 3 , wherein the expandable scaffold is disposed inside or around an implantable carrier, and the implantable carrier is disposed at a location within the living subject.
6. The expandable scaffold of claim 3 , wherein the 3D porous structure is formed by injecting the composite material into a bone defect or a tissue defect of the living subject using an application device, such that the injected composite material uptakes bodily fluid of the living subject and expand to self-fit in the bone defect or the tissue defect.
7. The expandable scaffold of claim 6 , wherein the application device is a syringe.
8. The expandable scaffold of claim 1 , wherein the expandable scaffold is loaded with a plurality of cells, drugs, antibiotics, growth factors or proteins.
9. The expandable scaffold of claim 1 , wherein the second material is selected from a group consisting of hydroxyapatite, apatite, bone particles, calcium phosphate family or particles of multiple phases, calcium sulfate family or particles of multiple phases, graphitic materials, graphene, carbon nanotubes, carbon spheres, gold, silver nanomaterials, magnesium, zinc, and a combination thereof.
10. The expandable scaffold of claim 9 , wherein the second material is nanosized hydroxyapatite (nHA).
11. The expandable scaffold of claim 10 , wherein external and internal surfaces of the 3D porous structure, and/or a bulk of the 3D porous structure have a surface coating.
12. The expandable scaffold of claim 11 , wherein a thickness of the surface coating ranges from 0.001 nm to 10 cm.
13. The expandable scaffold of claim 11 , wherein the surface coating is formed of a biocompatible and biodegradable polymer material, comprising: (poly(α-esters), polyglycolide, polylactide, poly(L-lactic acid)(PLLA), poly(D-lactic acid) (PDLA), poly(D,L-lactic acid)(PDLLA), poly(lactide-co-glycolide), polyhydroxyalkanoates, poly(3-hydroxybutyrate), PHBV, Polycaprolactone(PCL), Poly(propylene fumarate)(PPF), polyanhydrides, polyacetals, poly(ortho esters), polycarbonates, poly(trimethylene carbonate)(PTMC), poly(desaminotyrosyltyrosine alkyl ester carbonates)(PDTEs), polyurethanes, polyphosphazenes, (poly[bis(trifluoroethoxy)phosphazene], polyphosphoesters, poly(ester ether)s, polydioxanone (PDO), poly(β-amino esters)(PBAEs), poly(anhydride ester)s, poly(ester urethane)s, urethanes, polyurethanes, poly(ethylene glycol)(PEG), poly(propylene glycol)(PPG), triblock pluronic ([PEG]n-[PPG]m-[PEG]n), pluronic, PEG diacrylate (PEGDA), PEG dimethacrylate (PEGDMA), collagen, elastin, elastin-like polypeptides (ELPs), aAlbumin, fibrin, natural poly(amino acids), poly(γ-glutamic acid), poly(L-lysine), synthetic poly(amino acids), poly(L-glutamic acid), poly(aspartic acid), poly(aspartic acid)(PAA), polysaccharides, hyaluronic acid (HA), chondroitin sulfate (CS), polycaprolactone (PCL), chitin, chitosan, alginate, dextran, collagen, agarose, mannan or inulin.
14. The expandable scaffold of claim 10 , wherein the expandable scaffold is designed to have a non-uniform density and packing density.
15. The expandable scaffold of claim 10 , wherein the 3D porous structure has a porosity ranging from 1% to 99%.
16. The expandable scaffold of claim 10 , wherein construction of the expandable scaffold is done by 3D bio-printing and hybrid printing and deposition technology by layer-by-layer deposition.
17. A bone regeneration system, comprising:
the expandable scaffold of claim 1 , configured to be disposed at a location within a living subject in which bone formation and regeneration are required, such that the 3D porous structure of the expandable scaffold uptakes bodily fluid of the living subject and expands at the location within the living subject, wherein the second material includes bone particles.
18. The bone regeneration system of claim 17 , wherein the expandable scaffold is disposed in a bone defect of the living subject, such that the 3D porous structure of the expandable scaffold uptakes the bodily fluid of the living subject and expands to self-fit in the bone defect.
19. The bone regeneration system of claim 17 , wherein the expandable scaffold is disposed inside or around an implantable carrier, and the implantable carrier is disposed at the location within the living subject.
20. The bone regeneration system of claim 17 , further comprising an application device configured to inject the composite material into the location within the living subject, such that the injected composite material uptakes bodily fluid of the living subject and expand to form the expandable scaffold.
21. The bone regeneration system of claim 20 , wherein the application device is a syringe.
22. A soft tissue regeneration system, comprising:
the expandable scaffold of claim 1 , configured to be disposed within a tissue defect of a living subject in which soft tissue formation and regeneration are required, such that the 3D porous structure of the expandable scaffold uptakes bodily fluid of the living subject and expands to self-fit in the tissue defect.
23. The soft tissue regeneration system of claim 22 , wherein the soft tissue of the living subject includes muscle, skin, nerve, blood arteries and vessels of the living subject.
24. A bleed stopping device, comprising:
the expandable scaffold of claim 1 , configured to be disposed at a location of a living subject in which bleeding occurs, such that the 3D porous structure of the expandable scaffold uptakes blood of the living subject and expands to stop the bleeding.
25. An expandable scaffold, comprising:
a three-dimensional (3D) porous structure comprising a composite material composed by a first material and a second material,
wherein the first material comprises a mixture of a first biocompatible and biodegradable polyurethane polymer having a linear expansion of 100.44%, and a second biocompatible and biodegradable polyurethane polymer having a linear expansion of 42.11%, wherein a mass ratio of the first biocompatible and biodegradable polyurethane polymer to the second biocompatible and biodegradable polyurethane polymer is in a range from 1/1 to 9/1; and
wherein the 3D porous structure has a tunable expansion capacity, and when applied in a liquid, is configured to uptake the liquid and expand from an original volume to an expansion volume up to 10000 times of the original volume.